Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.SummaryDifference0.1%

- Check11 days agoChange DetectedGlossary display has been added, and a new 'Last Update Submitted that Met QC Criteria' indicator appears, along with a 'No FEAR Act Data' notice and a revision banner for v3.4.0. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' information has been removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no changes to study details or content.SummaryDifference0.1%

- Check47 days agoChange DetectedA new consolidated Locations section lists five sites (California, Georgia, Louisiana, Oklahoma, Vermont) and replaces the previous separate state location entries; the page revision is v3.3.3.SummaryDifference0.6%

- Check76 days agoChange DetectedThe page revision changed from v3.2.0 to v3.3.2; no study data or page functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRemoved the government funding status notice, an informational banner — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.